News
.jpg)
COVISHIELD Completes Enrolment of Phase III clinical trials under partnership of ICMR and Serum Institute of India
The strategic alliance between SII and the ICMR will advance India’s role in the global race to develop COVID-19 vaccines. ICMR is providing continuous support to SII in conducting and funding the ongoing clinical trials of COVISHIELD across 15 centres in India
Azooka, Bon Ayu, Nirmai Health win National Startup Awards 2020
Three well-known life sciences startups, Azooka Life Sciences, Nirmai Health Analytx and Bon Ayu are among the winners of National Startups Awards 2020 announced by the Government of India in 16 technology sectors. The awards were announced on October 6,2020.
Tata firm, CSIR lab develop Feluda, world’s first CRISPR based COVID-19 test kit
India’s efforts against COVID-19 saw a major fillip when the regulator, Drug Controller General of India (DCGI) gave permission for the commercial launch of India's first Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) COVID-19 test on September 19. The test is names “Feluda'.
CRISPR, the revolutionary genetic "scissors," honored by Chemistry Nobel
The award went jointly to Dr Emmanuelle Charpentier of Max Planck Unit for the Science of Pathogens and Dr Jennifer A. Doudna of the University of California, Berkeley, "for the development of a method for genome editing."
UK firm Native Antigen launches 10 new MABs reagents for COVID-19 detection kits
Ten new monoclonal antibodies recognize distinct Spike protein epitopes on SARS-CoV-2 and the antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein. Different epitopes support identification of matched-pair reagents for immunoassay development
Archives
The Crucibles of Enterprise 2021
